Prediction of haemorrhage in the early stage of acute myeloid leukaemia by flow cytometric analysis of platelet function

British Journal of Haematology

Volumn 128, Issue 4, 2005, Pages 526-532

  Leinoe, Eva Birgitte ^a,b   Hoffmann, Marianne Hutchings ^a   Kjaersgaard, Erik ^a   Nielsen, Joern Dalsgaard ^a   Bergmann, Olav Jonas ^a   Klausen, Tobias Wirenfeldt ^a   Johnsen, Hans Erik ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b Gentofte Hospital ^*  (Denmark)

Author keywords

Acute myeloid leukaemia; Bleeding disorders; Flow cytometry; P selectin; Platelets

Indexed keywords

CD63 ANTIGEN; D DIMER; FIBRINOGEN; GLYCOPROTEIN IB ALPHA; PADGEM PROTEIN; PROTEIN; PROTEIN PAC 1; THROMBIN RECEPTOR ACTIVATING PEPTIDE; TUMOR MARKER; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLEEDING; CANCER STAGING; CLINICAL ARTICLE; DISEASE COURSE; EARLY CANCER; FLOW CYTOMETRY; HEMOSTASIS; HUMAN; LETHALITY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTHROMBIN TIME; THROMBIN TIME; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; BLOOD SPECIMEN COLLECTION; FLOW CYTOMETRY; HEMORRHAGE; HEMOSTASIS; HUMANS; LEUKEMIA, MYELOID; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET COUNT; PLATELET FUNCTION TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 14144250221     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.05335.x     Document Type: Article

References (35)

1. Andre, P. (2004) P-selectin in haemostasis. British Journal of Haematology, 126, 298-306.
2. Arbuck, SG, Ivy, SP & Setser, A. (1999) The Revised Common Toxicity Criteria: Version 2.0. Available at: http://ctep.info.nih.gov.
3. Barbui, T. & Falanga, A. (2001) Disseminated intravascular coagulation in acute leukemia. Seminars in Thrombosis and Hemostasis, 27, 593-604.
4. Beutler, E. (1993) Platelet transfusions - the 20,000/μL trigger. Blood, 81, 1411-1413.
5. Callow, C.R., Swindell, R., Randall, W. & Chopra, R. (2002) The frequency of bleeding complications in patients with haematological malignancy following the introduction of a stringent prophylactic platelet transfusion policy. British Journal of Haematology, 118, 677-682.
6. Cambien, B. & Wagner, D.D. (2004) A new role in hemostasis for the adhesion receptor P-selectin. Trends in Molecular Medicine, 10, 179-186.
7. Chong, B.H., Murray, B., Berndt, M.C., Dunlop, L.C., Brighton, T. & Chesterman, C.N. (1994) Plasma P-selectin is increased in thrombotic consumptive platelet disorders. Blood, 83, 1535-1541.
8. Cowan, D.H., Graham, R.C. & Baunach, D. (1975) Platelet defect in leukemia - platelet ultrastructure, adenine-nucleotide metabolism, and release reaction. Journal of Clinical Investigation, 56, 188-200.
9. Creutzig, U., Ritter, J., Budde, M., Sutor, A. & Schellong, G. (1987) Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia - associations with hyperleukocytosis and acute monocytic leukemia. Cancer, 60, 3071-3079.
10. Dunlop, L.C., Skinner, M.P., Bendall, L.J., Favaloro, E.J., Castaldi, P.A., German, J.J., Gamble, J.R., Vadas, M.A. & Berndt, M.C. (1992) Characterization of Gmp-140 (P-Selectin) as a circulating plasma-protein. Journal of Experimental Medicine, 175, 1147-1150.
11. Estey, E.H., Keating, M.J., Mccredie, K.B., Bodey, G.P. & Freireich, E.J. (1982) Causes of initial remission induction failure in acute myelogenous leukemia. Blood, 60, 309-315.
12. Friedman, I.A., Leithold, S.L. Schwartz, S.O. (1964) Platelet function defects with bleeding - early manifestation of acute leukemia. Archives of Internal Medicine, 113, 177-185.
13. Graafsma, Y.P., Prins, M.H., Lensing, A.W.A., Huismar, M.V. & Buller, H.R. (1997) Bleeding classification in clinical trials: observer variability and clinical relevance. Thrombosis and Haemostasis, 78, 1189-1192.
14. Hagberg, I.A. & Lyberg, T. (2000) Blood platelet activation evaluated by flow cytometry: optimised methods for clinical studies. Platelets, 11, 137-150.
15. Han, T., Stutzman, L, Cohen, E. & Kim, U. (1966) Effect of platelet transfusion on haemorrhage in patients with acute leukemia - an autopsy study. Cancer, 19, 1937-1942.
16. Harris, N.L., Jaffe, E.S., Diebold, J., Flandrin, G., Muller-Hermelink, H.K., Vardiman, J., Lister, T.A. & Bloomfield, C.D. (2000) The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Modern Pathology, 13, 193-207.
17. Harrison, P. & Cramer, E.M. (1993) Platelet alpha-granules. Blood Reviews, 7, 52-62.
18. Harrison, P., Horton, A., Grant, D., Briggs, C. & MacHin, S. (2000) Immunoplatelet counting: a proposed new reference procedure. British Journal of Haematology, 108, 228-235.
19. Israels, S.J., Gerrard, J.M., Jacques, Y.V., Mcnicol, A., Cham, B., Nishibori, M. & Bainton, D.F. (1992) Platelet dense granule membranes contain both granulophysin and P-Selectin (Gmp-140). Blood, 80, 143-152.
20. Kim, H., Lee, J.H., Choi, S.J., Kim, W.K., Lee, J.S. & Lee, K.H. (2004) Analysis of fatal intracranial haemorrhage in 792 acute leukemia patients. Haematologica, 89, 622-624.
21. Kwaan, H.C., Wang, J. & Boggio, L.N. (2002) Abnormalities in hemostasis in acute promyelocytic leukemia. Hematological Oncology, 20, 33-41.
22. Leinoe, EB, Hoffmann, MH, Kjaersgaard, E & Johnsen, HE (2004) Multiple platelet function defects identified by flow cytometry at diagnosis in acute myeloid leukemia. British Journal of Haematology, 127, 76-84.
23. Lester, T.J., Johnson, J.W. & Cuttner, J. (1985) Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic-leukemia and hyperleukocytosis. American Journal of Medicine, 79, 43-48.
24. Lisiewicz, J. (1978) Mechanisms of hemorrhage in leukemias. Seminars in Thrombosis and Hemostasis, 4, 241-267.
25. Mcever, R.P. (1990) The clinical significance of platelet membrane glycoproteins. Hematology-Oncology Clinics of North America, 4, 87-105.
26. Michelson, A.D. (1996) Flow cytometry: a clinical test of platelet function. Blood, 87, 4925-4936.
27. Nair, S., Ghosh, K., Kulkarni, B., Shetty, S. & Mohanty, D. (2002) Glanzmann's thrombasthenia: updated. Platelets, 13, 387-393.
28. Nieuwenhuis, H.K., Vanoosterhout, J.J.G., Rozemuller, E., Vaniwaarden, F. & Sixma, J.J. (1987) Studies with a monoclonal-antibody against activated platelets - evidence that secreted 53,000-molecular weight lysosome-like granule protein is exposed on the surface of activated platelets in the circulation. Blood, 53 838-845.
29. Niiya, K., Hodson, E., Bader, R., Byersward, V., Koziol, J.A., Plow, E.F. & Ruggeri, Z.M. (1987) Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation - relationship to the binding of fibrinogen and platelet-aggregation. Blood, 70, 475-483.
30. Pisciotto, P.T., Benson, K., Hume, H., Classman, A.B., Oberman, H., Popovsky, M., Hines, D. & Anderson, K. (1995) Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients. Transfusion, 35, 498-502.
31. Ruan, C., Tobelem, G., Mcmichael, A.J., Drouet, L., Legrand, Y., Degos, L., Kieffer, N., Lee, H. & Caen, J.P. (1981) Monoclonal-antibody to human-platelet glycoprotein-1.2. Effects on human-platelet function. British Journal of Haematology, 49, 511-519.
32. Shattil, S.J., Hoxie, J.A., Cunningham, M. & Brass, L.F. (1985) Changes in the platelet membrane glycoprotein-IIb-IIIa complex during platelet activation. Journal of Biological Chemistry, 260, 1107-1114.
33. Stalfelt, A.M., Brodin, H., Pettersson, S. & Eklof, A. (2003) The final phase in acute myeloid leukaemia (AML) - a study on bleeding, infection and pain. Leukemia Research, 27, 481-488.
34. Subramaniam, M., Frenette, P.S., Saffaripour, S., Johnson, R.C., Hynes, R.O. & Wagner, D.D. (1996) Defects in hemostasis in P-selectin-deficient mice. Blood, 87, 1238-1242.
35. Trotti, A., Byhardt, R., Stetz, J., Gwede, C., Corn, B., Fu, K., Gunderson, L., McCormick, B., Morris, M., Rich, T., Shipley, W. & Curran, W. (2000) Common toxicity criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. International Journal of Radiation Oncology Biology Physics, 47, 13-47.